In order to transfect melanoma specifically by receptor-mediated endocytosis we prepared dioctadecyl aminoglycylspermine (lipospermine)^DNA complexes with [Nle 4 ,D-Phe 7 ]-K-MSH(4^10), a pseudo-peptide analogue of K-melanocyte stimulating hormone (K-MSH) linked to a thiol-reactive phospholipid. With these complexes we obtained an up to 70-fold increase of transfection with B16-F1 melanoma cells. However when B16-G4F, an K-MSH receptor negative melanoma cell line was transfected, an up to 700-fold increased transfection efficiency was observed. The peptide hormone analogue was equally efficient when it was only mixed with lipospermine^DNA complexes without covalent coupling. In addition to melanoma cells we also obtained up to 30-fold increased transfection with BN cells (embryonic liver cells). Our data show that an K-MSH analogue increased transfection independently of the MSH receptor expression but reaches efficiencies approaching those obtained with peptides derived from viral fusion proteins. The absence of targeting of constructs containing [Nle 4 ,D-Phe 7 ]-K-MSH(4^10) can probably be attributed due to the relatively modest number of MSH receptors at the surface of melanoma. We suggest, however, that the peptide hormone analogue used in this study has membrane-active properties and could be of interest as helper agent to enhance non-viral gene delivery presumably by endosomal-destabilizing properties. ß
Introduction
One of the critical steps for gene therapy is the transfer of genes into target cells. With viral vectors high transfection e¤ciencies may be achieved, but these systems carry limited lengths of DNA, are potentially hazardous for patients and do not allow a convenient targeting of speci¢c cell types. In comparison to viral vectors, synthetic transfection constructs are less e¤cient but they are still attractive because of the possibility to overcome most of these problems. For these reasons many e¡orts are concen-trated on increasing transfection e¤ciencies and tissue speci¢city of synthetic vectors. (Poly)cationic molecules, able to complex and condense DNA [14 ] seemed to be very attractive but no real breakthrough has occurred. E¡orts on improving lipidbased gene transfer have been done by di¡erent ways: direct modi¢cation of the cationic lipid [5, 6] , optimization of the formulation of lipid^DNA complexes [7, 8] and addition of compounds, such as amphipathic peptides [9^11] or helper lipids [5, 7, 8] , that facilitate transfer across the endosomal membranes. On the other hand, concerning tissue speci¢c targeting, a variety of ligands have been examined, for review see [12, 13] . Recently, a small peptide ligand has been successfully used to transfect pancreatic cells [14] . In an other study, ¢broblasts and HeLa cells have been targeted by an integrin binding peptide coupled to PEI [15] . Such small peptides have the advantage that they can be readily synthesized and may be less antigenic in vivo.
The incidence of melanoma in the Caucasian population is still increasing [16] and because of the dif¢culties to treat its disseminating forms, there is a considerable interest in speci¢c therapies for this type of tumors. In gene therapy, several approaches seem to be promising, as for example the use of genes encoding HLA or cytokines [17, 18] . Localized gene transfer will improve the treatments, as the destruction of healthy tissue could be considerably limited. In order to target speci¢cally melanoma cells we have chosen to use a superpotent analogue of K-melanocyte stimulating hormone (K-MSH), derived from [Nle 4 ,D-Phe 7 ]-K-MSH(4^10) (compound 1, Fig. 1 ) [19] . Compared to the natural hormone, this stable pseudo-peptide analogue of the fragment 4^10 of K-MSH, abbreviated here [NDP]-K-MSH(4^10), binds with a slightly lower a¤nity to the MSH receptor melanocortin receptor 1 (MC1) [19] , a G-protein-coupled receptor which is speci¢cally expressed on pigmented cells and in higher density on melanoma cells [20, 21] . Importantly, it was shown that [NDP]-K-MSH(4^10) has a very low non-speci¢c uptake in vivo and could be modi¢ed at both N-or Cterminal ends, for example by coupling to macromolecules or other molecular moieties, without a¡ecting its a¤nity for the receptor [19,22^24] . For e¤cient gene delivery by ligand^receptor interaction, endocytosis of the complex is necessary. In this respect, it has been shown for B16 melanoma cells, that [NDP]-K-MSH is rapidly internalized, accompanied by a loss or down-regulation of surface MSH receptors, suggesting an internalization of the [NDP]-K-MSHr eceptor complex [25] .
In this study we have investigated the e¤ciency of gene transfer to mouse melanoma cells using [NDP]-K-MSH(4^10) coupled to an amphiphilic anchor mixed to a dioctadecyl aminoglycylspermine (lipospermine)^DNA complex. We have found that this ligand originally used for targeting purposes enhanced transfection but independently of the MSHreceptor expression. Our results suggest that [NDP]-K-MSH(4^10) might be endowed with hitherto unrecognized membrane-active properties that favor transfection. Fig. 1 ) was obtained high-performance liquid chromatography (HPLC)-puri¢ed from Neosystem (Strasbourg, France). DPPE-(polyethylene glycol (PEG)) 3 -Mal was prepared in our laboratory as described [26, 27] .
Materials and methods

Materials
Compound 1, HS-CH 2 -CH 2 -CONH-Gly-[Nle 4 , D-Phe 7 ]-K-MSH(4^10) (see
Cell cultures
B16-F1 and B16-G4F mouse melanoma cell lines were maintained at 37³C in a humidi¢ed air^CO 2 (5%) atmosphere using modi¢ed Eagle's medium (MEM) with Earle's salts (Gibco, Paisley, UK) supplemented with 10% heat-inactivated fetal calf serum (FCS, Gibco), 2 mM L-glutamine, 1% MEM nonessential amino acid solution, 1% MEM vitamin solution, 50 U/ml of penicillin and 50 Wg/ml streptomycin. 3T3 cells were cultured in DMEM supplemented with 2 mM L-glutamine, 100 U/ml penicillin, 100 Wg/ml streptomycin and 10% FCS. BN cells were cultured in DMEM with 0.4% glucose, supplemented with 10% FCS, 100 U/ml streptomycin, 100 IU/ml penicillin, 0.1 mg/ml kanamycin and 286 mg/ml L-glutamine.
Transfection protocols
Transfections were performed with 2 Wg of the plasmid pCMV-Luc (Dr. M.A. Zanta, Strasbourg, France) per well in 24 well plates. For this amount of DNA, 6 nmol of lipospermine (Transfectam, Promega, gift of J.-P. Behr) are required to neutralize all the negative charges carried by the phosphates of the plasmid (i.e., molar ratio of lipospermine nitrogens to DNA phosphate N/P = 1).
Preparation of the transfection particles: Method A ( Fig. 1 ): Ligand 1 was ¢rst conjugated to DPPE-(PEG) n -Mal, a thiol-reactive amphiphilic anchor and then added to lipospermine and plasmid to yield the transfection particles at given N/P ratios.
A solution of DPPE-(PEG) n -Mal (0.12^0.6 nmol) in chloroform was evaporated under vacuum. The resulting ¢lm was dispersed by bath-sonication in a mixture of 40 Wl ethanol and 40 Wl of HEPES-bu¡-ered saline (HBS) (pH 6.7) containing 15 mM NaCl and reacted for 2 h, at room temperature, with compound 1 previously treated with tris-(2-carboxyethyl)phosphine (TCEP) to reduce any disul¢de bonds; ¢nally, unreacted DPPE-(PEG) n -Mal was treated with an excess (¢ve equivalents) of 2-mercaptoethanol during 20 min. The same was done with controls which lacked 1. After evaporation under vacuum, the resulting ¢lm was bath sonicated in the presence of 20 Wl H 2 O and 70 Wl HBS. For three wells, lipospermine (in 10% ethanol) was then added to the coupling reaction, the solution was vortexmixed and 6 Wg DNA (in double-distilled water) added.
Method B (Fig. 1) : Alternatively, the coupling reaction of compound 1 was performed with preformed lipospermine^DNA particles of given N/P ratios containing the thiol reactive derivative DPPE-(PEG) n -Mal. In this case lipospermine and DPPE-(PEG) n -Mal (0.12^0.6 nmol) in chloroform were evaporated under vacuum. The lipid ¢lm was sonicated in 90 Wl HBS, 6 Wg DNA added and vortexed. TCEP-treated compound 1 was reacted for 2 h with the lipospermine^DNA complexes and unreacted DPPE-(PEG) n -Mal was treated with an excess (¢ve equivalents) of 2-mercaptoethanol during 20 min.
After the preparation of compound 1-DPPE^lipo-spermine^DNA complexes 200 Wl of MEM without serum was added to them and the transfection mixture was added to cells (5U10 4 cells/well) which were seeded in 24 well plates (Costar) 18 h before transfection to reach 60^70% con£uence during transfection. Culture medium was replaced with 1 ml serumfree medium before transfection and 10% FCS was added 2 h after transfection. Transfections were also done in 1 ml fresh complete medium containing 10% FCS. In this case relative values for transfections with compound 1 were only slightly lower compared to transfections in serum-free medium (results not shown). The cells were cultured for an additional 24 h period and tested for reporter gene expression. Luciferase expression was quanti¢ed on cell lysates by measuring the light emission with a luminometer (Biolumat LB 9500; Berthold, Paris, France) using a commercial kit (Promega). Each transfection experiment was done in triplicate and is expressed as relative light units (RLU) integrated over 10 s, per mg of cell protein (BCA assay, Pierce, Paris, France). If not indicated otherwise experiments were performed twice or three times. For all studies representative experiments are shown because of variations of absolute values between individual experiments, depending on plasmid batches and state of the cells.
Results
Optimization of lipospermine^DNA lipoplexes for targeted transfection of mouse melanoma cells
To observe targeted transfection it is, in many cases, necessary to transfect cells with complexes that otherwise, in the absence of speci¢c ligands, lead to only low transfection e¤ciencies. This can be observed for example with constructs that have a global charge near neutrality (N/P = 1) [8] or which are negatively charged as reported by Lee and Huang [28] for folate targeted constructs. In this latter work, it was shown that under optimal transfection conditions, when using positively charged complexes, no further enhancement of transfection could be observed in the presence of the speci¢c ligand; moreover this transfection was no more cell speci¢c suggesting that the non-speci¢c electrostatic interactions between cells and the positively charged complexes were superseding the speci¢c ligand^receptor interactions. Similar considerations were discussed by Scha¡er et al. [29] favoring the existence of a limited window where ligand-mediated transfection can be observed.
In comparison to the many other cell types transfected with the lipospermine^DNA complexes encoding luciferase reporter gene [30] , B16-F1 mouse melanoma cells were the most easily transfected, even with constructs prepared at low N/P in the presence of 150 mM NaCl ( Fig. 2A) . In contrast, when the complexes were formed in HBS containing only 15 mM NaCl, transfection reached lowest e¤ciencies at N/P = 1 and increased again when the particles were globally negatively charged (analyzed down to N/P = 0.3 in Fig. 2B ). Similar e¡ects have been observed by Lee and Huang [28] , which can be explained by the occurrence of small particles size for positively and negatively charged particles and large particle size for isoelectric' (i.e. neutral) particles.
As low N/P are su¤cient to transfect e¤ciently B16-F1 cells, we wondered whether the transfection of these cells was still dependent on proteoglycans as reported for other cell types [31, 32] . Proteoglycans are the most negative-charged components on the cell surface and they were shown to interact with lipoplexes/polyplexes carrying net positive charges. The involvement of proteoglycans in transfection could be demonstrated e.g. by inhibiting the glycosamine sulfation with sodium chlorate or by competition with free glycosaminoglycans [31, 32] . To test the role of sulfated proteoglycans in the transfection of B16-F1 melanoma cells, the cells were grown in the presence of 35 mM sodium chlorate for 4 and 48 h and transfected with lipospermine^DNA complexes prepared at di¡erent N/P ratios. At 48 h, luciferase expression was less than 30% of the control even in the case of negatively charged transfection complexes (Fig. 3) . To test if free exogenous glycosaminoglycans could competitively inhibit gene delivery, B16-F1 cells were transfected in the presence of heparin (40 Wg/ml). Con¢rming the results of other groups [31, 32] , this resulted in a dramatic decrease of transfection e¤ciency to levels less than 1% of controls under all charge conditions tested (not shown). Thus, even in the case of negatively charged particles it seems that there is disruption of the complexes and liberation of DNA as predicted for positively charged particles by Szoka et al. [33, 34] .
Preparation of targeted constructs
The preparation of the targeted constructs was achieved according to a strategy we have developed before for the coupling of e.g. triantennary galactosyl ligands to transfection constructs [5] or peptides to the surface of liposomes [27] . Thus compound 1, which corresponds to the pseudo-peptide [Nle 4 ,DPhe 7 ]-K-MSH(4^10) that was extended at its N-terminus with a thiol containing spacer-arm, can be easily reacted with a thiol-reactive derivative of phosphatidylethanolamine such as DPPE-(PEG) 3 -Mal that serves as an amphipilic anchor (Fig. 1) in lipoplexes. The conjugation of 1 to the transfection constructs was realized according to two alternative methods ( Fig. 1 ): (i) method A: 1 was ¢rst coupled to DPPE-(PEG) 3 -Mal (2^10 mol% of lipospermine) and the reaction product was mixed with lipospermine before making the complexes with the plasmid; (ii) method B: 1 was coupled to preformed transfec- tion complexes made by mixing lipospermine and DPPE-(PEG) 3 -Mal (2^10 mol% of lipospermine) to the plasmid. As seen in Fig. 4B , coupling with di¡er-ent amounts of 1 after formation of the lipid^DNA complexes (method B) resulted in strongly decreased transfection e¤ciencies; however when 1 was ¢rst coupled to DPPE-(PEG) 3 -Mal and the complexes formed after (method A), there was a 40-fold increase in e¤ciency starting at 5 mol% of 1 (Fig.  4A) . When 10 mol% of compound 1 was used we did not observe any further increase in transfection e¤ciency (results not shown).
We also tested the in£uence on the transfection e¤ciencies of the spacer-arm length between the ligand and the transfection particle. We tried two different PEG-based spacers, i.e. a short spacer with three oxyethylene units and a longer spacer with 45 (average) units. We observed more than a 1000-fold decrease of transfection e¤ciencies when lipospermine is mixed with DPPE-(PEG) 45 -Mal-compound 1 (with long PEG-spacers), independently of the coupling method, suggesting an inhibitory e¡ect of the longer spacer (Fig. 4A,B) . In fact, it has been shown that PEG alone on liposomes inhibits adhesion to cells [35] . As the long spacers did not improve transfections, all further experiments were than done with short spacers. For all following studies, complexes were prepared in HBS (pH 6.7) containing 15 mM NaCl.
Transfection of K-MSH receptor positive or negative mouse melanoma cells
When B16-F1 cells, which have been shown to express about 10 000 MSH receptors on the cell surface [21] , were transfected with targeted constructs, prepared according to method A, we observed increased e¤ciencies with complexes containing 5 mol% of compound 1 (Figs. 4 and 5) and a up to 70-fold increase over controls (Fig. 5 ) when compound 1 (TCEP-and 2-mercaptoethanol-treated) was simply mixed with lipospermine, in the absence of DPPE-(PEG) 3 -Mal, before formation of the complexes with DNA. However when an excess of free [NDP]-K-MSH was added to the cell culture medium we never could observe any competition; Fig. 4 . E¡ect of the spacer-arm length and coupling method on the transfection e¤ciencies of B16-F1 cells by lipospermineD NA complexes (N/P = 1). Compound 1 was conjugated before (method A, A) or after (method B, B) mixing the thiol-reactive derivative DPPE-(PEG) n -Mal with lipospermine and pCMVLuc plasmid as described in Section 2. Luciferase activities were measured 24 h after transfection (2 Wg plasmid per well) and are represented as the mean values ( þ S.D.) of triplicates. Spacers: S = (PEG) 3 and L = (PEG) 45 . The proportions of the ligand are given as mol% of lipospermine used to prepare the lipoplexes. on the contrary, in most cases we even observed a further increase in transfection yield (Fig. 5) .
As a control, the same experiments were performed with B16-G4F, i.e., a mutant line derived of B16 melanoma cells which is lacking the K-MSH receptor [36] . With this cell line we obtained up to a 700-fold increased e¤ciency when compound 1 was mixed with lipospermine^DNA complexes without DPPE-(PEG) 3 -Mal. Again, we could not compete with an excess of free [NDP]-K-MSH in the culture medium (Fig. 6 ). To determine optimal charge ratios of lipospermine for the transfection of B16-G4F cells with compound 1/^lipospermine^DNA complexes, constructs containing 1 coupled to DPPE-(PEG) 3 Mal or free were prepared with N/P ratios ranging from 0.5 to 6. Highest e¡ects of compound 1 on transfection yields in comparison to controls (i.e. 30^90-fold, see Fig. 7 ), were observed with particles near neutrality, i.e. N/P = 0.5^2. Enhancement was highest (90-fold) with N/P = 2 and compound 1D PPE. Compound 1, coupled or free was, up to 20 times, less e¡ective with more positively charged complexes (N/P = 4 and 6). As observed in the former experiments (Figs. 5 and 6 ), when DPPE-(PEG) 3 -Mal was mixed with lipospermine no increase of luciferase activity was observed (results not shown).
The data shown in Fig. 7 are representative for several experiments. Except for the construct DOGS^DPPE-(PEG) 3 -Mal^compound 1 N/P = 1, the covalent coupling of 1 resulted in increased transfection e¤ciency. At present, we can not explain why at N/P = 1 this was not observed in this one experiment.
In order to test whether compound 1, either covalently coupled to DPPE-(PEG) 3 -Mal or mixed with lipospermine during the preparation of the complexes, was e¡ective with other cell types than melanoma cells, we repeated the experiments with ¢bro-blasts (3T3 cells), and hepatocytes (BN cells). In BN cells, compound 1 covalently linked or added to neutral particles (N/P = 1) increased the transfection yields up to 30-fold (Fig. 8) . However, increased transfection e¤cacy was also observed with the construct containing DPPE-(PEG) 3 -Mal in the absence of compound 1. A similar e¡ect of thiol-reactive derivatives on transfection yields was observed previously by Kichler et al., 1995 [37] . Nevertheless the fact that constructs that did not contain the maleimide group were also potent in the presence of compound 1 (Fig. 8, last bar) indicates that this peptide is active per se in the transfection process.
In contrast, with 3T3 cells we could not observe any signi¢cant increase in transfection triggered by compound 1 (Fig. 8) .
Discussion
It is now well established that mouse and human melanoma cells possess speci¢c high-a¤nity receptors for K-MSH [20, 21, 38, 39] . For that reason this peptide was utilized for the development of diagnostic tools of melanoma but also for therapeutic purposes; thus, K-MSH derivatives have been successfully used to visualize melanoma metastases in patients and malignant melanomas have been specifically targeted with MSH^toxin fusion proteins [40] . For targeting purposes K-MSH has many potential advantages: it presents a high a¤nity for its receptors, analogues have been synthesized which are highly stable in vivo and which have also excellent a¤nities for example for the MC1 receptor [19, 21] , because if their small size these peptides should be poorly immunogenic. Finally these analogues can be easily modi¢ed, e.g. at their N-terminus, without losing a¤nity for the receptor. For these reasons K-MSH, and in particular its superpotent analogue [NDP]-K-MSH(4^10), seemed to us an attractive tool for targeting melanoma cells with the aim of gene delivery.
In many cases, a condition to observe targeted gene transfer is to associate speci¢c ligands to transfection particles that present by themselves a limited interaction with the target cells and thus generally achieve only low transfection levels. In our preliminary assays to determine optimal conditions for targeting gene transfer to melanoma cells with compound 1 we have observed that B16-F1 cells are easily transfectable with lipoplexes. In general with other cell lines tested with cationic lipid-based gene transfer complexes, e.g. with lipospermine [30] , optimal transfection is observed with highly positive particles (i.e. N/P v 6). This positive charge is thought to promote the binding of the complexes to the negatively charged surface of cells and their uptake via adsorptive endocytosis. In contrast, B16-F1 melanoma cells are optimally transfected with lesser positively particles (N/P ratio between 2 and 4) and are transfectable, albeit in lower yield, with neutral or even net negatively charged complexes obtained with lipospermine under standard conditions. This could be explained tentatively by the fact that melanoma cells overexpress negatively charged proteoglycans [41] . In agreement with this proposal we have shown that inhibition of the sulfation of its surface proteoglycans decreased drastically the transfection e¤ciency. This result, however, does not explain why cells are still transfected with complexes pre- pared with a global negative charge. Related to these results it should be noted that relatively e¤cient transfection with particles that carry a net negative charge have also been observed by others [42, 43] . In line with our aim, we could however decrease background transfection by preparing the complexes in HBS and the lowest levels were reached with neutral particles.
In our transfection assays we have shown that a superactive analogue of K-MSH used with lipospermine^DNA complexes increased strongly the transfection of melanoma cells. Enhancement was only observed when coupling was performed using method A. As the coupling methods described by Remy et al. [5] , even decreased transfection e¤ciencies of B16-F1 cells (not shown) we changed the protocol and included a drying step after coupling and 2-mercaptoethanol treatment which eliminated ethanol and 2-mercaptoethanol (see Section 2.3). We suppose that particles prepared according method B inhibit transfection of melanoma cells because 2-mercaptoethanol remains in the transfection solution.
With these complexes, we could however not demonstrate any cell speci¢c targeting, as we could not compete targeting with an excess of free [NDP]-K-MSH. In addition B16-G4F cells which lack MC1 receptors on their surface are even better transfected than B16-F1 cells. With these cells transfection is improved up to 700-fold by the presence of the ligand 1.
Thus, even if there is some cell speci¢c targeting, the unspeci¢c enhancement due to compound 1 is so high that it would mask it. This seems likely, considering the relatively low number of MSH receptors expressed on the cell surface in comparison to other receptors which have been used successfully for targeting gene delivery constructs, such as for example folate receptors (V2.5U10 5 sites/cell) [24] . As compound 1 was also found to have an e¡ect on transfection yield when it is just mixed with lipospermine when making the complexes with the plasmid, we suppose that the free ligand could interact with the constructs most probably via hydrophobic interactions (see below).
Using the same lipospermine^DNA lipoplexes, the e¡ect of 1 on the transfection yield was also tested of other cell types such as murine ¢broblasts and liverderived cells. We could observe an enhanced transfection only with the liver cells. When compound 1 is just mixed with lipospermine, transfection increases as observed with coupled 1. We conclude from these results that the e¡ect of compound 1 is not restricted to cells that express the MSH receptor and therefore does not increase the transfection yields of the lipospermine-based lipoplexes by targeting this receptor.
The e¡ect of the peptide [NDP]-K-MSH on the transfection e¤ciency of lipospermine^DNA complexes is therefore more reminiscent to the one described for viral fusogenic peptides when associated to polyplexes/lipoplexes [44] . These membrane-active peptides, which act by destabilizing the endosomal membranes, also lack cell speci¢city and for example INF6, a peptide deriving from in£uenza virus, which is one the most e¡ective of these agents, was found to increase transfection up to 1000-fold with 1.5 and 2 charge eq. particles [11] . In contrast to compound 1, no enhancement was observed with neutral particles. Under optimal transfection conditions, i.e. with the most positively charged particles, only slight enhancement could be obtained with compound 1 and this feature was also observed with viral fusogenic peptides [11] . But in contrast to fusogenic peptides compound 1 strongly increases transfection with particles which are nearly neutral, N/P between 0.5 and 2.
The mechanism for the membrane-destabilizing action of compound 1 remains to be fully elucidated. But it seems that it might be di¡erent from the known fusogenic peptides: among the peptides that Kichler et al. have tested [11] , only the acidic (negatively charged) ones gave good results with lipospermine. In contrast to these viral peptides, compound 1 has a net positive charge at neutral and acidic pH. There are, however, some hints on a possible membrane activity of K-MSH and [NDP]-K-MSH. The group of Schwyzer has shown some time ago that K-MSH and other peptide hormones that bind to G-protein-coupled receptors interact directly with lipid bilayers [45, 46] . More recent biophysical studies by Biaggi et al. [47, 48] and Macedo et al. [49] have demonstrated that indeed K-MSH penetrates lipid bilayers. Our own studies in this area demonstrate that the analogues of K-MSH are endowed with hitherto unrecognized, and unexpected, membrane-active properties such as the promotion of membrane fu-sion (D. Lima de Souza et al., to be published) which could well explain our present data.
Taken together, compound 1 does not seem to be a useful peptide for the targeting of cells such as melanomas. This is probably due to the relatively low expression of MC1 receptors on the surface of these cells. However, 1 seems to be a new kind of membrane-active peptide that could be used under neutral transfection conditions, in particular for melanoma cells. The other advantages, as low immunogenicity, resistance to degradation are good prerequisites for in vivo gene transfer.
